Upregulation of thymidine phosphorylase in chronic glomerulonephritis and its role in tubulointerstitial injury

Nephron Clin Pract. 2006;102(3-4):c133-42. doi: 10.1159/000089672. Epub 2005 Nov 10.

Abstract

Chronic tubulointerstitial injury (CTI), commonly a sequel to chronic glomerulonephritis (CGN), is associated with the proliferation of new blood vessels. Angiogenesis is an essential process in chronic inflammation, and is controlled by a number of angiogenic factors including thymidine phosphorylase (TP). Knowledge of TP in renal disease is still rudimentary, and its role in CGN has not been explored. We analyzed the expression of TP by RTPCR, immunohistology and in situ hybridization in 20 human kidneys with CGN. To evaluate the degree of angiogenesis, we counted the microvessel density (MVD). MVD was significantly higher in all categories of CGN, between 19.7 +/- 7.7 and 58.9 +/- 7.5, compared to control value, 12.7 +/- 5.0 (p < 0.05). MVD was increased in areas of abundant mononuclear cell infiltration with minimal interstitial fibrosis, and decreased or absent in areas of marked fibrosis. There was a significant correlation between MVD and interstitial fibrosis (p < 0.0001). TP mRNA was upregulated for all categories of CGN. TP was strongly expressed by mononuclear inflammatory cells and in most atrophic tubules. Each MVD and interstitial volume was significantly correlated with both the number of TP+ mononuclear cells and TP+ tubular cells, respectively (p < 0.0001). We have demonstrated an upregulation of TP and increase in MVD in areas of CTI in a variety of CGN. The up-regulation of TP may contribute to angiogenesis, which may play a critical role in the progression of interstitial fibrosis in CGN.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Chronic Disease
  • Disease Progression
  • Female
  • Glomerulonephritis / complications*
  • Glomerulonephritis / metabolism*
  • Glomerulonephritis / pathology
  • Humans
  • Male
  • Middle Aged
  • Neovascularization, Pathologic
  • Thymidine Phosphorylase / biosynthesis*
  • Up-Regulation*

Substances

  • Thymidine Phosphorylase